Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
Lianhua Qingwen, patented and marketed for the severe acute respiratory syndrome (SARS) epidemic since 2003 in China, can significantly reduce the duration of fever, fatigue and cough.
“LH capsules confer therapeutic effects on Covid-19, improving the rate of recovery from symptoms, shortening recovery time and improving recovery from chest radiological abnormalities. In light of the efficacy and safety profiles, LH capsules may be considered for the treatment of Covid-19.”
Hu K., Guan W., Bi Y., et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2020:153242. doi: 10.1016/j.phymed.2020.153242
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066964/#bib45
No comments:
Post a Comment